您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > S 14506
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
S 14506
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
S 14506图片
CAS NO:135722-25-7
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
A 5-HT1Areceptor agonist
Cas No.135722-25-7
Canonical SMILESO=C(C1=CC=C(C=C1)F)NCCN2CCN(CC2)C3=CC=CC4=CC=C(C=C43)OC
分子式C24H26FN3O2
分子量407.5
溶解度DMSO: soluble,Ethanol: soluble
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

S 14506 is an agonist of the serotonin (5-HT) receptor subtype 5-HT1A.1,2,3,4It selectively binds 5-HT1Aover 5-HT1B, 5-HT1C, 5-HT2, and 5-HT3receptors (Kis = 0.98, 281.8, 31.6, 229, and >1,000 nM, respectively) but also binds the dopamine D2receptor (Ki= 4.57 nM) in radioligand binding assays.1,2S 14506 stimulates GTPase activity in HEK293 cell membranes expressing 5-HT1A-Gαi1or 5-HT1A-Gαo1fusion proteins in a concentration-dependent manner.3It reduces immobility time in the forced swim test in rats with a minimum effective dose (MED) of 0.01 mg/kg.4S 14506 (0.0025-0.63 mg/kg) increases punished responding in a pigeon conflict procedure, indicating anxiolytic-like activity.1

1.Colpaert, F.C., Koek, W., Lehmann, J., et al.S 14506: A novel, potent, high-efficacy 5-HT1A agonist and potential anxiolytic agentDrug Dev. Res.26(1)21-48(1992) 2.Protais, P., Chagraoui, A., Arbaoui, J., et al.Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodentsEur. J. Pharmacol.271(1)167-177(1994) 3.Milligan, G., Kellett, E., Dacquet, C., et al.S 14506: Novel receptor coupling at 5-HT1A receptorsNeuropharmacology40(3)334-344(2000) 4.Schreiber, R., Brocco, M., Gobert, A., et al.The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonistsEur. J. Pharmacol.271(2-3)537-541(1994)